Nurix Stock

nurixtx.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $48.38MM

Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels by controlling ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Nurix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Nurix’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Nurix.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Nancy Pryer Ph.D
Chief Development Officer
John Kuriyan Ph.D
Pierre Beaurang Ph.D
Chief Business Officer
Michael Rape Ph.D
Arthur Sands Ph.D
Chief Executive Officer & Board Member
Arthur Weiss MD

Board Members

David Lacey MD
Arthur Sands Ph.D
Robert Tjian Ph.D
The Column Group
Timothy Kutzkey Ph.D
The Column Group
Jeffrey Tong Ph.D
Third Rock Ventures

Nurix’s stock FAQs


Can you buy Nurix’s stock?

As Nurix is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Nurix, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge's Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Nurix’s stock?

To invest in a private company like Nurix’s through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Nurix’s stock?

Yes, you may be able to sell your Nurix’s stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Nurix’s stock?

If you hold private company shares of Nurix’s - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Nurix’s on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Nurix’s a public company?

No, Nurix’s is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Nurix’s stock price?

Nurix is a privately held company and therefore does not have a public stock price. However, you may access Nurix’s private market stock price with Forge Data.

What is Nurix’s stock ticker symbol?

Nurix does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Nurix Therapeutics Announces Key Additions to its Board of Directors

Xconomy: With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field

Gilead Sciences is turning to Nurix Therapeutics in an effort to discover new drugs that harness the cellular machinery our bodies use to dispose of
Updated on: Jul 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.